Today: 11 November 2025
Subscribe
Browse Tag

Health

Oura Ring 4 Ceramic Collection: Why This Stylish Health Wearable Could Revolutionize Your Self‑Tracking

Oura Ring 4 Ceramic Collection: Why This Stylish Health Wearable Could Revolutionize Your Self‑Tracking

Oura reinvents its smart ring through material science Oura has dominated the smart‑ring category — more than half of the 5.5 million rings sold to date were shipped in the last year wired.com. The Finnish–American company is now addressing fashion‑conscious and health‑obsessed consumers with the Oura Ring 4 Ceramic Collection, a series of premium rings made of zirconia ceramic. Unlike metal rings coated with paint, the color in zirconia ceramic comes from minerals baked into the material, so the hues remain rich even when the ring surface is scratched businesswire.com. Zirconia is lightweight and hypoallergenic, making it comfortable for extended wear. Oura’s
1 October 2025
 ·  ·  ·  · 
‘Hoarse Voice’ Could Be COVID: “Stratus” Variant Surges—Symptoms Doctors Flag, Where It’s Rising, and What Still Works

‘Hoarse Voice’ Could Be COVID: “Stratus” Variant Surges—Symptoms Doctors Flag, Where It’s Rising, and What Still Works

What is the “Stratus” COVID variant? “Stratus” is the colloquial name for XFG, a recombinant Omicron descendant (from LF.7 and LP.8.1.2). WHO added XFG to its monitoring list in late June and, based on available evidence, concluded the “additional public‑health risk … is low.” WHO’s lab summary notes spike‑protein changes (e.g., at positions 478 and 487) that can modestly increase immune escape compared with earlier JN.1‑family strains. World Health Organization Globally, XFG gained speed over the summer. WHO’s dashboard reports XFG was ~67% of submitted sequences in the week ending 31 Aug 2025; the runner‑up, NB.1.8.1 (“Nimbus”), accounted for ~21%.
28 September 2025
 ·  ·  ·  · 
Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Key Facts Scientific Breakthroughs & New Research Leading our roundup are several significant scientific and medical breakthroughs. Researchers in New York unveiled a potential “universal” antiviral strategy, reporting compounds that neutralized seven different viruses across multiple families in lab tests gavi.org. By targeting sugar molecules (glycans) common to many enveloped viruses, the team identified four small molecules that blocked infections by pathogens ranging from coronaviruses to Nipah and Ebola gavi.org. “This is the kind of antiviral tool the world urgently needs. If a new virus emerges tomorrow, we currently have nothing to deploy. These compounds offer the potential to be
30 August 2025
 ·  ·  ·  ·  ·  ·  · 
Game-Changing Vaccines, Breakthrough Drugs, and a CDC Shakeup: Biotech & Health News Roundup

Game-Changing Vaccines, Breakthrough Drugs, and a CDC Shakeup: Biotech & Health News Roundup

In-Depth Report COVID-19 Vaccines and U.S. Public Health Upheaval Targeted Fall Boosters, But Access Tightened: U.S. health authorities approved new monovalent COVID-19 vaccines (by Pfizer–BioNTech, Moderna, and Novavax) updated for the 2025–26 season reuters.com. Unlike prior booster rollouts, the FDA restricted under-65 eligibility to those with risk factors, aligning with guidance from HHS Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic reuters.com. The change marks a sharp departure from broad eligibility in previous years. Officials and experts voiced concern that narrowing access could sow confusion over insurance coverage and leave many younger adults unprotected reuters.com reuters.com. Notably, the FDA
28 August 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Smart Ring Showdown: Why the New Circular Ring 2 May Outshine Oura and the Rest

Smart Ring Showdown: Why the New Circular Ring 2 May Outshine Oura and the Rest

Key Takeaways and Quick Facts Circular Ring 2 In-Depth: Features, Specs and Experience Health and Fitness Tracking The Circular Ring 2 is packed with sensors and algorithms aimed at quantifying your health from every angle. At its core, it uses optical sensors (PPG) to continuously monitor heart rate, heart rate variability (HRV), blood oxygen saturation (SpO₂), respiratory rate, skin temperature, and more circular.xyz circular.xyz. These biometrics feed into a comprehensive system that analyzes over 140 data points to gauge your daily fitness and wellness. Overall, Circular Ring 2 aims to be a full-spectrum health tracker on your finger. It’s not
26 August 2025
 ·  ·  ·  · 
FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

Regulatory Announcements: Approvals & Rejections Clinical Trial Breakthroughs & Research Highlights Industry Deals, Mergers & Investments Public Health Policy & Governance Updates Emerging Diseases & Vaccine News This comprehensive roundup highlights the fast-moving developments in biotech, pharma, and health over the past 48 hours. From life-saving drugs and high-stakes deals to public health challenges, the landscape is evolving daily. As always, readers are advised to consult original sources and official health guidance for more details. Sources: Key information has been drawn from Reuters, AP News, FDA/CDC releases, and expert commentary to ensure accuracy and timeliness reuters.com reuters.com reuters.com thewellnews.com reuters.com
25 August 2025
 ·  ·  ·  · 
Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights Medical Research & Innovation Public Health & Policy Developments Sources: Ionis HAE drug approval pharmexec.com biopharmadive.com; BioPharmaDive on Dawnzera pricing and positioning biopharmadive.com biopharmadive.com; AbbVie Rinvoq AA trial via FiercePharma fiercepharma.com; Lancet Neurology SAPPHIRE trial results neurologylive.com neurologylive.com; Reuters – Kite/Gilead’s Interius acquisition reuters.com and Interius press release interiusbio.com; PharmExec on XOMA-Mural deal ts2.tech; Reuters – J&J $2B NC facility and quote ts2.tech ts2.tech; Reuters – Apollo Hospitals stake sale ts2.tech; BiopharmaTrend on Kyorin adopting Elix AI platform biopharmatrend.com biopharmatrend.com; Laotian Times – Amgen Golden Ticket
23 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Space Shocks, Medical Miracles, and Climate Wake-Up Calls – Science News Roundup (Aug 19–20, 2025)

Space Shocks, Medical Miracles, and Climate Wake-Up Calls – Science News Roundup (Aug 19–20, 2025)

Space Exploration & Astronomy Medical Research & Biotechnology Environmental Science Climate Change Artificial Intelligence Energy Physics Sources: The above information is drawn from recent press releases, journal publications, and reports dated August 19–20, 2025, including NASA announcements science.nasa.gov science.nasa.gov, ScienceDaily and Sci-News summaries sciencedaily.com sci.news, university press releases sciencedaily.com sciencedaily.com, Reuters newswire reports reuters.com, and peer-reviewed study findings sciencedaily.com scitechdaily.com. All content has been verified for accuracy as of August 20, 2025.
20 August 2025
 ·  ·  ·  ·  · 
Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Sector – Big Deals, Funding, and FDA Drama Pharma & Drug Development – Approvals, Showdowns, and Safety Signals Medical & Clinical Updates – Guidelines and Safety Notices Public Health & Policy – Vaccine Rift, Medicare Cuts, and Wellness Initiatives Sources: Key news and expert quotes were gathered from Fierce Biotech fiercebiotech.com fiercebiotech.com, Fierce Pharma fiercepharma.com fiercepharma.com, Fierce Healthcare fiercehealthcare.com fiercehealthcare.com, STAT News statnews.com statnews.com, the Florida Phoenix floridaphoenix.com floridaphoenix.com, CIDRAP cidrap.umn.edu cidrap.umn.edu, and other authoritative sources as cited above. Each development is linked to its original reporting for further reading. The roundup covers events and announcements from August 18–19,
19 August 2025
 ·  ·  ·  ·  ·  · 
Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

New Drug Approvals & Clinical Trial Results Mergers, Acquisitions & Partnerships (No other major M&A deals were announced during Aug 17–18, but this Lilly-Superluminal alliance highlights the continued investment in AI-driven R&D.) Regulatory & Policy Updates Public Health & Epidemiology (No major new COVID-19 variant or pandemic threat emerged over the weekend, but health officials continue to monitor familiar foes like measles, polio, and others as vaccination lapses threaten to reverse public health gains.) Scientific & Medical Breakthroughs (Additional notable research: Other studies this week reported that a simple walking gait adjustment can ease knee arthritis as much as medication,
18 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based on part 1 of an ongoing trial showing liver health improvement. Tonix Pharmaceuticals’ Tonmya, or TNX-102 SL, was approved August 15 for fibromyalgia, the first new fibromyalgia therapy in 15 years, with two Phase 3 trials showing significantly reduced daily pain versus placebo at 14 weeks and a potential peak U.S. sales of about $800 million. Pfizer’s inclacumab, a P-selectin inhibitor acquired via the 2022 $5.4 billion Global
16 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Official press releases, government health agency updates, and reputable media coverage were used in this report (including Reuters, Fierce Biotech/Pharma, Bloomberg, FDA/CDC/DSHS releases, and peer-reviewed journals). All source links are provided inline above for reference.
14 August 2025
 ·  ·  ·  ·  ·  ·  · 
1 2
Go toTop